Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 9

1.

Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine.

Fava M, Mulroy R, Alpert J, Nierenberg AA, Rosenbaum JF.

Am J Psychiatry. 1997 Dec;154(12):1760-2.

PMID:
9396960
2.

Venlafaxine: a 2003 update.

Gutierrez MA, Stimmel GL, Aiso JY.

Clin Ther. 2003 Aug;25(8):2138-54. Review.

PMID:
14512125
3.

Clinical evaluation of venlafaxine.

Ballenger JC.

J Clin Psychopharmacol. 1996 Jun;16(3 Suppl 2):29S-35S; discussion 35S-36S. Review.

PMID:
8784646
4.

[Venlafaxine withdrawal syndrome: report of six cases and review of the literature].

Pinzani V, Giniès E, Robert L, Peyrière H, Abbar M, Blayac JP.

Rev Med Interne. 2000 Mar;21(3):282-4. Review. French.

PMID:
10763190
5.

Venlafaxine extended-release: a review of its use in the management of major depression.

Wellington K, Perry CM.

CNS Drugs. 2001;15(8):643-69. Review.

PMID:
11524036
6.

A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder.

Allgulander C, Nutt D, Detke M, Erickson J, Spann M, Walker D, Ball S, Russell J.

J Psychopharmacol. 2008 Jun;22(4):417-25. doi: 10.1177/0269881108091588.

PMID:
18635722
7.

Cardiovascular safety in depressed patients: focus on venlafaxine.

Feighner JP.

J Clin Psychiatry. 1995 Dec;56(12):574-9. Review.

PMID:
8530334
8.

[Effects of venlafaxine extended release formulation on the clinical management of patients].

Carrasco JL, Díaz-Marsá M, López-Ibor JJ.

Actas Esp Psiquiatr. 2005 May-Jun;33(3):147-53. Review. Spanish.

PMID:
15918081
9.

[Cost-effectiveness of venlafaxine for the treatment of depression and anxiety. Bibliographic review].

Baca Baldomero E, Rubio-Terrés C.

Actas Esp Psiquiatr. 2006 May-Jun;34(3):193-201. Review. Spanish.

PMID:
16736393
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk